Diagnosing phenotypes of single-sample individuals by edge biomarkers

Journal of Molecular Cell Biology

Volumn 7, Issue 3, 2015, Pages 231-241

  Zhang, Wanwei ^a   Zeng, Tao ^a   Liu, Xiaoping ^a   Chen, Luonan ^a,b  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b SHANGHAITECH UNIVERSITY   (China)

Author keywords

big biological data; disease diagnosis; edge biomarker; edge feature; progressive stages

Indexed keywords

BIOLOGICAL MARKER; EDGE BIOMARKER; UNCLASSIFIED DRUG; TUMOR MARKER;

ADVANCED CANCER; ARTICLE; CANCER RISK; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE EXPRESSION; GENETIC MARKER; LUNG ADENOCARCINOMA; METASTASIS; SURVIVAL RATE; TRANSCRIPTION REGULATION; ADENOCARCINOMA; BIOLOGY; BREAST NEOPLASMS; EARLY DIAGNOSIS; GENETICS; HUMAN; LUNG NEOPLASMS; MORTALITY; PHENOTYPE; PROPORTIONAL HAZARDS MODEL;

ADENOCARCINOMA; BIOMARKERS, TUMOR; BREAST NEOPLASMS; COMPUTATIONAL BIOLOGY; EARLY DIAGNOSIS; HUMANS; LUNG NEOPLASMS; NEOPLASM METASTASIS; PHENOTYPE; PROPORTIONAL HAZARDS MODELS;

EID: 84938867264     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mjv025     Document Type: Article

References (48)

1. Auffray, C., Charron, D., and Hood, L. (2010). Predictive, preventive, personalized and participatory medicine: back to the future. Genome Med. 2, 57.
2. Backer, M.V., Backer, J.M., and Chinnaiyan, P. (2011). Targeting the unfolded protein response in cancer therapy. Methods Enzymol. 491, 37-56.
3. Bunney, T.D., and Katan, M. (2010). Phosphoinositide signalling in cancer: beyond PI3K and PTEN. Nat. Rev. Cancer 10, 342-352.
4. Chen, L., Wang, R.-S., and Zhang, X.-S. (2009). Biomolecular Networks: Methods and Applications in Systems Biology. Hoboken: Wiley.
5. Chen, J., Guo, K., and Kastan, M.B. (2012a). Interactions of nucleolin and ribosomal protein L26 (RPL26) in translational control of human p53 mRNA. J. Biol. Chem. 287, 16467-16476.
6. Chen, L., Liu, R., Liu, Z.P., et al. (2012b). Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers. Sci. Rep. 2, 342.
7. Dos Remedios, C.G., and Chhabra, D. (2008). Actin-Binding Proteins and Disease. New York: Springer.
8. Gazda, H.T., Preti, M., Sheen, M.R., et al. (2012). Frameshift mutation in p53 regulator RPL26 is associated with multiple physical abnormalities and a specific pre-ribosomal RNA processing defect in diamond-blackfan anemia. Hum. Mutat. 33, 1037-1044.
9. He, D., Liu, Z.P., Honda, M., et al. (2012). Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma. J. Mol. Cell Biol. 4, 140-152.
10. Herbst, R.S., Heymach, J.V., and Lippman, S.M. (2008). Lung cancer. N. Engl. J. Med. 359, 1367-1380.
11. Hood, L., and Flores, M. (2012). A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. N. Biotechnol. 29, 613-624.
12. Hood, L., and Friend, S.H. (2011). Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat. Rev. Clin. Oncol. 8, 184-187.
13. Jiang, P., Enomoto, A., Jijiwa, M., etal. (2008). An actin-binding protein Girdin regulates the motility of breast cancer cells. Cancer Res. 68, 1310-1318.
14. Kowanetz, M., and Ferrara, N. (2006). Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin. Cancer Res. 12, 5018-5022.
15. Kummerfeld, S.K., and Teichmann, S.A. (2006). DBD: a transcription factor prediction database. Nucleic Acids Res. 34, D74-D81.
16. Lai, Y., Wu, B., Chen, L., et al. (2004). A statistical method for identifying differential gene-gene co-expression patterns. Bioinformatics 20, 3146-3155.
17. Lee, E., and Yuspa, S.H. (1991). Changes in inositol phosphate metabolism are associated with terminal differentiation and neoplasia in mouse keratinocytes. Carcinogenesis 12, 1651-1658.
18. Li, C., Ge, M., Yin, Y., et al. (2012). Silencing expression of ribosomal protein L26 and L29 by RNA interfering inhibits proliferation of human pancreatic cancer PANC-1 cells. Mol. Cell. Biochem. 370, 127-139.
19. Li, N., Xi, Y., Tinsley, H.N., et al. (2013). Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/beta-catenin signaling. Mol. Cancer Ther. 12, 1848-1859.
20. Li, Y., Tan, B.B., Zhao, Q., et al. (2014). ZNF139 promotes tumor metastasis by increasing migration and invasion in human gastric cancer cells. Neoplasma 61, 291-298.
21. Listgarten, J., Neal, R.M., Roweis, S.T., et al. (2007). Difference detection in LC-MS data for protein biomarker discovery. Bioinformatics 23, e198-e204.
22. Liu, R., Li, M., Liu, Z.P., et al. (2012a). Identifying critical transitions and their leading biomolecular networks in complex diseases. Sci. Rep. 2, 813.
23. Liu, X., Liu, Z.P., Zhao, X.M., et al. (2012b). Identifying disease genes and module biomarkers by differential interactions. J. Am. Med. Inform. Assoc. 19, 241-248.
24. Liu, R., Yu, X., Liu, X., et al. (2014). Identifying critical transitions of complex diseases based on a single sample. Bioinformatics 30, 1579-1586.
25. Ma, Y., and Hendershot, L.M. (2004). The role of the unfolded protein response in tumour development: friend or foe? Nat. Rev. Cancer 4, 966-977.
26. Mor, G., Visintin, I., Lai, Y., et al. (2005). Serum protein markers for early detection of ovarian cancer. Proc. Natl Acad. Sci. USA 102, 7677-7682.
27. Ofir-Rosenfeld, Y., Boggs, K., Michael, D., et al. (2008). Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. Mol. Cell 32, 180-189.
28. Parkash, J., and Asotra, K. (2010). Calcium wave signaling in cancer cells. Life Sci. 87, 587-595.
29. Paul, R., Ewing, C.M., Jarrard, D.F., et al. (1997). The cadherin cell-cell adhesion pathway in prostate cancer progression. Br. J. Urol. 79(Suppl 1), 37-43.
30. Prevarskaya, N., Skryma, R., and Shuba, Y. (2011). Calcium in tumour metastasis: new roles for known actors. Nat. Rev. Cancer 11, 609-618.
31. Pudil, P., Novovicova, J., and Kittler, J. (1994). Floating search methods in feature-selection. Pattern Recognit. Lett. 15, 1119-1125.
32. Ren, Y., Zheng, J., Yao, X., et al. (2014). Essential role of the cGMP/PKG signaling pathway in regulating the proliferation and survival of human renal carcinoma cells. Int. J. Mol. Med. 34, 1430-1438.
33. Rouschop, K.M.A., van den Beucken, T., Dubois, L., et al. (2010). The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J. Clin. Invest. 120, 127-141.
34. Ryu, C.S., Kwak, H.C., Lee, K.S., et al. (2011). Sulfur amino acid metabolism in doxorubicin-resistant breast cancer cells. Toxicol. Appl. Pharmacol. 255, 94-102.
35. Sahni, N., Yi, S., Zhong, Q., et al. (2013). Edgotype: a fundamental link between genotype and phenotype. Curr. Opin. Genet. Dev. 23, 649-657.
36. Sun, S.Y., Liu, Z.P., Zeng, T., et al. (2013). Spatio-temporal analysis of type 2 diabetes mellitus based on differential expression networks. Sci. Rep. 3, 2268.
37. Tomida, S., Takeuchi, T., Shimada, Y., et al. (2009). Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis. J. Clin. Oncol. 27, 2793-2799.
38. Vivanco, I., and Sawyers, C.L. (2002). The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2, 489-501.
39. Vucenik, I., and Shamsuddin, A.M. (2003). Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic. J. Nutr. 133, 3778S-3784S.
40. Waldner, M.J., and Neurath, M.F. (2012). Targeting the VEGF signaling pathway in cancer therapy. Expert Opin. Ther. Targets 16, 5-13.
41. Wang, J., Huang, Q., Liu, Z.P., et al. (2011). NOA: a novel Network Ontology Analysis method. Nucleic Acids Res. 39, e187.
42. Wang, J., Sun, Y., Zheng, S., et al. (2013). APG: an Active Protein-Gene network model to quantify regulatory signals in complex biological systems. Sci. Rep. 3, 1097.
43. Weis, S.M., and Cheresh, D.A. (2011). Tumor angiogenesis: molecular pathways and therapeutic targets. Nat. Med. 17, 1359-1370.
44. Yang, H., Zhang, Q., He, J., et al. (2010). Regulation of calcium signaling in lung cancer. J. Thorac. Dis. 2, 52-56.
45. Yu, X., Li, G., and Chen, L. (2014). Prediction and early diagnosis of complex diseases by edge-network. Bioinformatics 30, 852-859.
46. Zeng, T., Sun, S.Y., Wang, Y., et al. (2013). Network biomarkers reveal dysfunctional gene regulations during disease progression. FEBS J. 280, 5682-5695.
47. Zeng, T., Zhang, W., Yu, X., et al. (2014). Edge biomarkers for classification and prediction of phenotypes. Sci. China Life Sci. 57, 1103-1114.
48. Zhang, W., Zeng, T., and Chen, L. (2014). EdgeMarker: identifying differentially correlated molecule pairs as edge-biomarkers. J. Theor. Biol. 362, 35-43.